<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="973">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04568655</url>
  </required_header>
  <id_info>
    <org_study_id>FAHGuangzhouYLS03</org_study_id>
    <nct_id>NCT04568655</nct_id>
  </id_info>
  <brief_title>The Noninvasive Ventilation to COVID-19 Patients</brief_title>
  <official_title>The Noninvasive Ventilation to COVID-19 Patients With Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Noninvasive ventilation(NIV) is an important treatment to the respiratory failure
      patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory
      failure.The NIV may reduce the intubtion rate.This research was taken to investigate the
      factor to the success of the noninvasive ventilation to the COVID-19 patients with
      respiratory failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Noninvasive ventilation(NIV) is an important treatment to the respiratory failure
      patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory
      failure.The NIV may reduce the intubtion rate.This research was taken to investigate the
      factor to the success of the noninvasive ventilation to the COVID-19 patients with
      respiratory failure.We wish to raise the success rate to COVID-19 patients with respiratory
      failure.More critically ill COVID-19 patients could avoid the intubtion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>success rate</measure>
    <time_frame>4 month</time_frame>
    <description>the sucess rate of the noninvasive ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the intubtion rate</measure>
    <time_frame>4 month</time_frame>
    <description>the intubtion rate of the COVID-19 patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood lymphocyte</measure>
    <time_frame>4month</time_frame>
    <description>blood lymphocyte of the COVID-19 patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B-type natriuretic peptide</measure>
    <time_frame>4 month</time_frame>
    <description>blood B-type natriuretic peptide of the COVID-19 patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procalcitonin</measure>
    <time_frame>4 month</time_frame>
    <description>blood procalcitonin of the COVID-19 patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>4 month</time_frame>
    <description>Oxygen Saturation of the COVID-19 patients</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">23</enrollment>
  <condition>Noninvavie Ventilation to Patients With COVID-19</condition>
  <arm_group>
    <arm_group_label>COVID-19 patients need noninvasive ventilation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>noninvasive ventilation</intervention_name>
    <description>noninvasive ventilation to support the COVID-19 patients with respiratory failure</description>
    <arm_group_label>COVID-19 patients need noninvasive ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        respiratory failure patients with COVID-19
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Shortness of breath, RR&gt;30 times per minute;

          2. At room air, SpO2 lower than 93%;

          3. The partial pressure of Arterial blood oxygen (PaO2)/the fraction of inspired oxygen
             (FiO2) ≤ 300mmHg;

          4. CT（computed tomography） chest imaging shows that lung damage develops significantly
             within 24 to 48 hours.

        Exclusion Criteria:

          1. Severe cardiovascular disease,

          2. respiratory arrest,

          3. cardiovascular instability (hypotension, arrhythmias, myocardial infarction),

          4. change in mental status or patients who were uncooperative, high risk of aspiration,
             viscous or copious

          5. secretions,

          6. recent facial or gastroesophageal surgery,

          7. craniofacial trauma, 8)fixed nasopharyngeal abnormalities,

        9）burns, 10) extreme obesity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>520120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>September 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2020</study_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Guangzhou Medical University</investigator_affiliation>
    <investigator_full_name>Zhang Jianheng</investigator_full_name>
    <investigator_title>The First Affiliated Hospital of Guangzhou Medical University</investigator_title>
  </responsible_party>
  <keyword>noninvavie ventilation</keyword>
  <keyword>COVID-19</keyword>
  <keyword>respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>the IPD are going to share after the paper published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

